Thermo Fisher Scientific Inc., of Waltham, Mass., has made a bold play in the molecular diagnostics market, including infectious disease testing, with its proposed $11.5 billion acquisition of Qiagen NV, of Venlo, Netherlands. Word of the deal comes after reports late last year that named Thermo Fisher as a potential suitor for Qiagen. However, in late December, Qiagen said it had wrapped up a review of potential strategic alternatives and decided its standalone business plan represented the best opportunity for value creation. Read More
With trauma patients and those suffering from bleeding disorders, being able to quickly assess a person’s bleeding risk can be lifesaving, but most current tests to measure clotting ability are laboratory-based and don’t provide immediate results. To that end, the U.S. FDA has granted Cleveland-based Xatek Inc. breakthrough device designation for its Clotchip portable blood clotting sensor. Read More
San Francisco-based startup Element Science Inc. has raised a massive financing in support of the first product that is part of its next-generation digital wearable platform. The $145.6 million series C financing is slated to support the company through clinical trial completion and commercial launch of its Jewel Patch Wearable Cardioverter Defibrillator. Read More
PERTH, Australia – Australian medication adherence technology firm Adherium Ltd. is relaunching itself after a management reshuffle and a successful capital raise of AU$5.4 million (US$3.5 million) to deploy a new commercial strategy. Read More
BOGOTA, Colombia – Argentina is the latest member of an international medical devices regulatory group. Joining the group could help the country speed up approvals and help the market for medical technology improve. Read More
Against the backdrop of the global spread of COVID-19, India announced restrictions Tuesday on the export of 26 active pharmaceutical ingredients (APIs) and formulations of those ingredients. Read More
New hires and promotions in the med-tech industry, including: Catasys, Cerus, Integer Holdings, Microbot Medical, Orchestra Biomed, Outset Medical, Venus Concept. Read More
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Angle, Cernostics, Integrity Implants, Moleculight, Pixium Vision, Quanta, Sensus Healthcare, Treace Medical. Read More
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adapthealth, Ao Foundation, Bioventrix, Capella Imaging, Curium, Dmh Worldwide, Healthline Medical Equipment, Ekare, Icotec, Infantdx, International Business Machines, Nalu Medical, Natera, Nevro, Northstar Medical Technologies, Pillo Health, Synergy Laboratories, Zevacor Molecular. Read More
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Access Vascular, Life Spine, Mauna Kea Technologies, Tivic Health, Xatek. Read More
Keeping you up to date on recent developments in oncology, including: Study identifies two different cancer stem cells in cervical cancer; How cancer cells hibernate…; …And who makes their bed; Blocking trash trashes MSI-hi tumors. Read More
